Literature DB >> 17462728

The performance of a bone-derived scaffold material in the repair of critical bone defects in a rhesus monkey model.

Huiqi Xie1, Fuchun Yang, Li Deng, Jingcong Luo, Tingwu Qin, Xiuqun Li, Guang-Qian Zhou, Zhiming Yang.   

Abstract

The efficacy and safety of a material derived from human bones in the repair of critical segmental bone defects are evaluated in a rhesus monkey model. Frozen human bones were chemically and physically processed into a partially demineralized and deproteinized material in blocks. The complete tissue-engineered (TE) bone was constructed of the material preseeded with allogeneic bone marrow mesenchymal stem cells (MSCs). The material alone and the TE bone were, respectively, implanted to bridge 2.5cm-long critical defects in right and left radii of 15 monkeys. At weeks 1, 2, 3, 6 and 12 post-implantation, the grafts were collected from three animals and assessed for the local expression of osteogenic markers, histological and roentgenographic features, and immune reactions. It was shown that defects were well repaired with both treatments whereas the bone defects in 2 additional untreated animals remained the same size after 12 weeks. In radii implanted with the TE bones, the repair processes were approximately 3 weeks faster and new bones were formed in a multipoint way. There was neither observable toxic effect nor overt immune rejection in any animals. Taken together, these observations suggest that the TE bone blocks composited of the allogeneic or xenogeneic bone-derived scaffold and allogeneic MSCs may provide an ideal method for repairing large segmental bone defects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462728     DOI: 10.1016/j.biomaterials.2007.04.001

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Maintenance and expansion of hematopoietic stem/progenitor cells in biomimetic osteoblast niche.

Authors:  Jing Tan; Ting Liu; Li Hou; Wentong Meng; Yuchun Wang; Wei Zhi; Li Deng
Journal:  Cytotechnology       Date:  2010-09-10       Impact factor: 2.058

2.  Characterization and differentiation potential of rabbit mesenchymal stem cells for translational regenerative medicine.

Authors:  A Bakhtina; M Tohfafarosh; A Lichtler; T Livingston Arinzeh
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-23       Impact factor: 2.416

3.  Long-term culture of leukemic bone marrow primary cells in biomimetic osteoblast niche.

Authors:  Li Hou; Ting Liu; Jing Tan; Wentong Meng; Li Deng; Hongtao Yu; Xingli Zou; Yuchun Wang
Journal:  Int J Hematol       Date:  2009-08-11       Impact factor: 2.490

Review 4.  Scaffold translation: barriers between concept and clinic.

Authors:  Scott J Hollister; William L Murphy
Journal:  Tissue Eng Part B Rev       Date:  2011-09-21       Impact factor: 6.389

5.  Restoration of bone defects using modified heterogeneous deproteinized bone seeded with bone marrow mesenchymal stem cells.

Authors:  Jun Li; Zeyu Huang; Liyan Chen; Xin Tang; Yue Fang; Lei Liu
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

6.  Enhancing effects of basic fibroblast growth factor and fibronectin on osteoblast adhesion to bone scaffolds for bone tissue engineering through extracellular matrix-integrin pathway.

Authors:  Li Feng; Yehong Li; Wenchao Zeng; Bo Xia; Dongsheng Zhou; Jing Zhou
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

7.  Evaluating the biodegradability of Gelatin/Siloxane/Hydroxyapatite (GS-Hyd) complex in vivo and its ability for adhesion and proliferation of rat bone marrow mesenchymal stem cells.

Authors:  Zeinab Neshati; Ahmad Reza Bahrami; Hossein Eshtiagh-Hosseini; Maryam M Matin; Mohammad Reza Housaindokht; Taymaz Tabari; Mohammad Amin Edalatmanesh
Journal:  Cytotechnology       Date:  2012-03-13       Impact factor: 2.058

Review 8.  Urine-derived stem cells: applications in skin, bone and articular cartilage repair.

Authors:  Wenqian Zhang; Jungen Hu; Yizhou Huang; Chenyu Wu; Huiqi Xie
Journal:  Burns Trauma       Date:  2021-11-26

Review 9.  Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.

Authors:  Andrei Laszlo; Dinesh Thotala; Dennis E Hallahan
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

10.  An anti-infection tissue-engineered construct delivering vancomycin: its evaluation in a goat model of femur defect.

Authors:  Zhengqi Chang; Tianyong Hou; Xuehui Wu; Fei Luo; Junchao Xing; Zhiqiang Li; Qianbo Chen; Bo Yu; Jianzhong Xu; Zhao Xie
Journal:  Int J Med Sci       Date:  2013-10-15       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.